San Diego, CA -- (SBWire) -- 05/09/2023 --YS Biopharma Co., Ltd. is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of YS Biopharma Co., Ltd. (NASDAQ: YS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by YS Biopharma Co., Ltd. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
China based YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. YS Biopharma Co., Ltd. reported that its Total Revenue rose from $257.01 million for the 12 months that ended on March 31, 2021, to $502.95 million for the 12 months period that ended on March 31, 2022, and that its Net Loss over those respective time periods declined from $191.82 million to $106 million.
Shares of YS Biopharma Co., Ltd. (NASDAQ: YS) declined from $18.44 per share on March 15, 2023, to as low as $1.32 per share on April 14, 2023.
Those who purchased shares of YS Biopharma Co., Ltd. (NASDAQ: YS) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About The Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
NASDAQ: YS Investor Alert: Investigation over Possible Securities Laws Violations by YS Biopharma Co., Ltd.
An investigation for investors in YS Biopharma Co., Ltd. (NASDAQ: YS) shares over potential securities laws violations by YS Biopharma Co., Ltd. was announced.